- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03858023
Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome
Study Overview
Detailed Description
This study evaluates the therapeutic effects of hippotherapy in children with Prader-Willi syndrome. Half of children will participate in hippotherapy for 15 weeks (30 minutes per sessions, twice a week, total 30 sessions, private lesson), while the other half will not receive hippotherapy.
The primary purpose of this study is to investigate effect of hippotherapy on motor function of Prader-Willi syndrome patients.
The secondary purpose is to compare motor function, obesity, and behavior of the children after the intervention with those parameters before the intervention.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: JI YOUNG CHOI
- Phone Number: +82-2-3410-3660
- Email: jy210.choi@samsung.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 06351
- Recruiting
- Samsung Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- can sit upright on the static surface
- can follow one step command
Exclusion Criteria:
- body wight > 35 kg
- serious medical conditions such as cardiac disease, pulmonary disease, uncontrolled epilepsy
- visual impairment, hearing impairment
- bleeding tendency, anticoagulation
- fracture within 6 months, major orthopedic surgery within 1 year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hippotherapy
Children in hippotherapy arm will participate in hippotherapy (30 min/sessions, twice a week, 15 weeks)
|
The hippotherapy program consists of 2 sessions per week for 15 weeks.
One session is 30-minute session.
The program involves 2 therapists and 3 personnel for safety issues.
|
No Intervention: Control
Children in control group will not receive hippotherapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical global Impression-Severity of illness (CGI-S) score
Time Frame: 15 weeks
|
The Clinical Global Impression (CGI) rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders.
The two components of CGI were used in this study: Severity of Illness (CGI-S) and Global improvement (CGI-I).
The clinician rates CGI-S on a 7-point scale from 1(normal) to 7(extremely ill) Thus, higher score means more severity outcomes
|
15 weeks
|
Clinical global Impression-Improvement (CGI-I) score
Time Frame: 15 weeks
|
The clinician rates CGI-I on a 7-point scale from 1(very much improved) to 7(very much worse) respectively.
Thus, higher score means worse outcomes.
|
15 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gross motor function assessed by GMFM-88 (Gross Motor Function Measure) score
Time Frame: 15 weeks
|
The 88 items of the GMFM are measured by observation of the child and scored on a 4-point ordinal scale (0=does not initiate, 1=initiates <10% of activity, 2=partially completes 10% to <100% of activity, 3=completes activity).
The items are weighted equally and grouped into 5 dimensions: (1) lying and rolling (17 items), (2) sitting (20 items), (3) crawling and kneeling (14 items), (4) standing (13 items), and (5) walking, running, jumping (24 items).
|
15 weeks
|
Pediatric Balance Scale
Time Frame: 15 weeks
|
The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in school-aged children.
The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points.
|
15 weeks
|
PWS (Prader-Willi syndrome) hyperphagia questionnaire
Time Frame: 15 weeks
|
The Hyperphagia Questionnaire is a robust tool for relating breakthroughs in the neurobiology of hyperphagia to in vivo food-seeking behavior and for examining the psychological and developmental correlates of hyperphagia in PWS.
It has 13 items and rated on a five-point scale (1 = not a problem to 5 = severe and/or frequent problem)
|
15 weeks
|
Child Behavior Checklist (CBCL)
Time Frame: 15 weeks
|
The Child Behavior Checklist (CBCL) is a widely used caregiver report form identifying problem behavior in children.
CBCL asks caregivers to rate 112 problems on a three-point scale (0 not true, 1 somewhat true, 2 very true).
It provides an internalizing and externalizing domain.
|
15 weeks
|
Obesity measured by DEXA (Dual-energy X-ray Absorptiometry)
Time Frame: 15 weeks
|
Dual-energy X-ray Absorptiometry is a means of measuring bone mineral density (BMD).
Two X-ray beams, with different energy levels, are aimed at the patient's bones.
When soft tissue absorption is subtracted out, the BMD can be determined from the absorption of each beam by bone.
Dual-energy X-ray absorptiometry is the most widely used and most thoroughly studied bone density measurement technology.
|
15 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: JEONG-YI KWON, MD, PHD, Samsung Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Overnutrition
- Nutrition Disorders
- Genetic Diseases, Inborn
- Intellectual Disability
- Abnormalities, Multiple
- Chromosome Disorders
- Obesity
- Syndrome
- Prader-Willi Syndrome
Other Study ID Numbers
- 2016-07-058-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prader-Willi Syndrome
-
University Hospital, ToulouseCompletedPrader Willi SyndromeFrance
-
University of FloridaNational Institutes of Health (NIH)Completed
-
Samsung Medical CenterCompletedObesity | Prader Willi Syndrome
-
Duke UniversityCanadian Institutes of Health Research (CIHR); National Institutes of Health... and other collaboratorsCompleted
-
California State University, FullertonUniversity of FloridaUnknownFamily-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study (APAH)Childhood Obesity | Prader Willi SyndromeUnited States
-
SanionaCompletedConfirmed Genetic Diagnosis of Prader-Willi SyndromeCzechia, Hungary
-
Weill Medical College of Cornell UniversityNational Institutes of Health (NIH); PWSAUSATerminatedPrader-willi SyndromeUnited States
-
Ferring PharmaceuticalsCompletedHyperphagia in Prader-Willi SyndromeUnited States
-
University of FloridaFoundation for Prader-Willi ResearchCompleted
-
ACADIA Pharmaceuticals Inc.RecruitingHyperphagia in Prader-Willi SyndromeUnited States, Canada
Clinical Trials on Hippotherapy
-
University of CadizCompletedSpasticity, Muscle | Cerebral Palsy, Spastic | Neuromuscular Diseases in ChildrenSpain
-
University of BrasiliaCompleted
-
University of IoanninaCompleted
-
Centre Hospitalier Universitaire de LiegeRecruiting
-
Creighton UniversityCompletedAutism Spectrum DisorderUnited States
-
Samsung Medical CenterNational Research Foundation of KoreaCompletedCerebral Palsy | Physical Activity | Attention DisorderKorea, Republic of
-
Central Michigan UniversityCompletedCerebral Palsy | Neuromuscular Diseases | Down Syndrome | Autism | Developmental Coordination DisorderUnited States
-
Halic UniversityCompleted
-
University of BrasiliaWilfrid Laurier UniversityCompletedQuality of Life | Parkinson's Disease
-
The Catholic University of KoreaSamsung Medical Center; Konkuk UniversityCompletedCerebral Palsy | Motor ActivityKorea, Republic of